Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 18.24% is in line with its 5-year average of 17.07%, around the middle of its 5-year range (10.31%–24.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.60% below its 12-month average of 21.86%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
18.24%
RETURN ON EQUITY (ROE) AVG TTM
21.86%
RETURN ON EQUITY (ROE) AVG 3Y
18.74%
RETURN ON EQUITY (ROE) AVG 5Y
17.07%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.60%
CURRENT VS 3Y AVG
-2.67%
CURRENT VS 5Y AVG
+6.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
12.21%
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
+49.35%
vs the sector median at left
Doximity, Inc.
Market Cap
$4.63B
Return on Equity (ROE)
18.24%
TTM Avg
21.86%
3Y Avg
18.74%
5Y Avg
17.07%
Market Cap
$3.19B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$6.65B
Return on Equity (ROE)
-43.83%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
Market Cap
$2.19B
Return on Equity (ROE)
-40.41%
TTM Avg
-45.75%
3Y Avg
-30.11%
5Y Avg
-18.95%
Market Cap
$8.10B
Return on Equity (ROE)
26.84%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$1.15B
Return on Equity (ROE)
-13.54%
TTM Avg
-40.81%
3Y Avg
-170.75%
5Y Avg
-114.78%
Market Cap
$495.81M
Return on Equity (ROE)
89.43%
TTM Avg
81.07%
3Y Avg
67.39%
5Y Avg
61.90%
Market Cap
$465.16M
Return on Equity (ROE)
-28.18%
TTM Avg
-52.50%
3Y Avg
-47.15%
5Y Avg
-47.15%
Market Cap
$9.93B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Doximity, Inc. (DOCS) | $4.63B | 18.24% | 21.86% | 18.74% | 17.07% |
| TransMedics Group, Inc. (TMDX)vs › | $3.19B | 29.28% | 27.86% | 4.54% | -12.45% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.65B | -43.83% | 25.09% | 5.57% | 0.40% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.19B | -40.41% | -45.75% | -30.11% | -18.95% |
| Oscar Health, Inc. (OSCR)vs › | $8.10B | 26.84% | -21.41% | -36.14% | -25.75% |
| Teladoc Health, Inc. (TDOC)vs › | $1.15B | -13.54% | -40.81% | -170.75% | -114.78% |
| NRC Health (NRC)vs › | $495.81M | 89.43% | 81.07% | 67.39% | 61.90% |
| Shoulder Innovations, Inc. (SI)vs › | $465.16M | -28.18% | -52.50% | -47.15% | -47.15% |
| Insulet Corp. (PODD)vs › | $9.93B | 26.39% | 25.41% | 19.99% | 14.02% |
| Henry Schein, Inc. (HSIC)vs › | $10.30B | 12.77% | 11.88% | 12.69% | 13.50% |
ROE
18.2%
ROA
15.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 18.24% |
| 2026-03-31 | 20.62% |
| 2025-12-31 | 24.45% |
| 2025-09-30 | 23.10% |
| 2025-06-30 | 22.93% |
| 2025-03-31 | 20.62% |
| 2024-12-31 | 19.53% |
| 2024-09-30 | 18.11% |
| 2024-06-30 | 17.57% |
| 2024-03-31 | 16.37% |
| 2023-12-31 | 15.92% |
| 2023-09-30 | 14.13% |
| 2023-06-30 | 11.99% |
| 2023-03-31 | 11.68% |
| 2022-12-31 | 12.78% |
| 2022-09-30 | 16.05% |
| 2022-06-30 | 16.72% |
| 2022-03-31 | 17.62% |
| 2021-12-31 | 16.63% |
| 2021-09-30 | 13.09% |
| 2021-06-30 | 10.31% |
| 2021-03-31 | 75.23% |
| 2020-12-31 | 26.60% |
